Alembic Pharmaceuticals Faces Market Challenges Amid Financial Performance Adjustments
Alembic Pharmaceuticals has recently experienced an evaluation adjustment due to shifts in its financial metrics and market position. The company's performance has diverged from broader market trends, with challenges in profitability and a flat quarterly performance, despite a strong debt servicing capability. Stakeholders should monitor these developments closely.
Alembic Pharmaceuticals has recently undergone an evaluation adjustment, reflecting changes in its underlying financial metrics and market position. The stock's technical indicators have shifted, with the MACD and Bollinger Bands signaling a bearish trend on both weekly and monthly bases. The company's performance over various time frames shows a notable divergence from broader market trends, particularly in the last year, where it has underperformed significantly compared to the BSE500 index.In terms of financial health, Alembic Pharmaceuticals has reported flat performance in its latest quarter, with operating profit declining at an annual rate over the past five years. Despite a strong ability to service debt, indicated by a low Debt to EBITDA ratio, the company has faced challenges, including a decrease in profits over the past year. The stock is currently trading at a discount relative to its peers, which may reflect investor sentiment regarding its long-term growth prospects.
Overall, the recent evaluation adjustment highlights the complexities surrounding Alembic Pharmaceuticals' market position and financial metrics, warranting close attention from stakeholders.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
